ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $222,440 | -21.0% | 8,196 | -10.5% | 0.00% | 0.0% |
Q2 2023 | $281,640 | -66.8% | 9,162 | -61.1% | 0.00% | -50.0% |
Q1 2023 | $848,903 | -60.5% | 23,561 | -56.7% | 0.00% | -66.7% |
Q4 2022 | $2,150,994 | -49.5% | 54,428 | -48.7% | 0.01% | -57.1% |
Q3 2022 | $4,263,000 | +34.1% | 106,103 | +40.2% | 0.01% | +40.0% |
Q2 2022 | $3,179,000 | +150.1% | 75,653 | +131.9% | 0.01% | +233.3% |
Q1 2022 | $1,271,000 | +505.2% | 32,626 | +518.0% | 0.00% | – |
Q4 2021 | $210,000 | +9.9% | 5,279 | 0.0% | 0.00% | – |
Q3 2021 | $191,000 | -11.6% | 5,279 | 0.0% | 0.00% | – |
Q2 2021 | $216,000 | -6.5% | 5,279 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $231,000 | – | 5,279 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |